skip to main content
Show Results with:

8 results  for Everything in this catalogue

Refined by: author: Ferris, Robert remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model

Kansy, Benjamin et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-2 -- BioMed Central

Online access

2
Material Type:
Article
Add to My workspace

Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle

Ferris, Robert et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-2 -- BioMed Central

Online access

3
Material Type:
Article
Add to My workspace

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients

Trivedi, Sumita et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

4
Material Type:
Article
Add to My workspace

PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer

Concha-Benavente, Fernando et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

5
Material Type:
Article
Add to My workspace

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)

Ferris, Robert et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

6
Material Type:
Article
Add to My workspace

Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment

Kansy, Benjamin et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

7
Material Type:
Article
Add to My workspace

PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL

Shayan, Gulidanna; Ferris, Robert

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-5 -- BioMed Central

Online access

8
Material Type:
Article
Add to My workspace

Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model

Srivastava, Raghvendra; Clump, David; Ferris, Robert

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

8 results  for Everything in this catalogue

Refine Search Results

Creation date 

From To

Searching Remote Databases, Please Wait